Core Viewpoint - The company, Aorui De Optoelectronics Co., Ltd., plans to invest approximately RMB 145 million in a computing power equipment procurement project to enhance its service capabilities [2][4]. Group 1: Investment Overview - The investment amount for the project is approximately RMB 145 million, which will be used primarily for purchasing servers, networking equipment, and accessories [4][7]. - The investment is within the authority of the board of directors and does not require shareholder approval, as it does not involve related transactions or constitute a major asset restructuring [5][6]. Group 2: Project Details - The project is being undertaken by the company's subsidiary, Shenzhen Zhikuanli Digital Technology Co., Ltd., in which the company holds a 99.925% stake [8]. - The project is currently in the preparatory stage and has not yet commenced construction [9]. Group 3: Financial Implications - The investment includes approximately RMB 115 million for server purchases, RMB 7 million for networking equipment and accessories, RMB 20 million for cluster supporting equipment leasing, and RMB 3 million for working capital [7]. - The project is expected to impact the company's future financial status and operational results, although the exact effects remain uncertain due to various market factors [10].

Core Viewpoint - Shanghai Yizhong reported a significant increase in net profit for 2025, driven by the inclusion of its core product in the national medical insurance directory and increased R&D investments [2]. Group 1: Company Performance - Shanghai Yizhong's total revenue for 2025 reached approximately 317.08 million yuan, a year-on-year increase of 82.72%, with net profit soaring by 819.42% to about 64.13 million yuan [2]. - Chipway Technology achieved a revenue of 394 million yuan in 2025, reflecting an 11.52% increase, while net profit decreased by 4.91% to 10.6 million yuan [5]. Group 2: Share Buybacks - XGIMI Technology plans to repurchase shares with a total fund of no less than 50 million yuan and no more than 100 million yuan, at a price not exceeding 159.51 yuan per share [3]. - Lexin Technology also intends to repurchase shares with a similar financial commitment, with a maximum price of 170.29 yuan per share [3]. Group 3: Risk Warnings - ST Kaiyuan anticipates a potential delisting risk warning due to expected negative net assets for 2025 [4]. Group 4: Important Investments - Aorui Technology's subsidiary plans to invest approximately 145 million yuan in computing power equipment [7]. - ZTE Corporation intends to invest 117 million yuan in a fund focused on new generation information technology and advanced manufacturing [10]. - Dawn Holdings is set to acquire a plastic and engineering plastic compound business in Vietnam for approximately 15.74 million USD [11]. Group 5: New Projects and Developments - Guangdong Electric Power A announced the successful commissioning of its Maoming Bohua Power Plant, with a total investment of 7.48 billion yuan and an expected annual power generation of 8.6 billion kWh [12]. - Ugreen Technology has submitted an application for H-share listing on the Hong Kong Stock Exchange [12].

| | | 2月2日重要公告精选 | | --- | --- | --- | | 类型 | 公司 | 主要内容 | | 热点 | 万丰股份 | 分散染料等产品价格未来预计变动幅度及其持续性存在不确定性 | | | 长飞光纤 | 与数据中心相关的新型产品占全球光纤光缆市场需求总量的比例较小 | | 项目投资 | 奥瑞德 | 深圳智算力拟投资约1.45亿元购买算力设备向客户提供服务 | | 合同中标 | 远东股份 | 子公司1月份中标/签约合计30.75亿元合同订单 | | 股权转让 | 国能目新 | 拟取得萨纳斯智维控制权 | | 业绩 | 芯导科技 | 2025年净利润1.06亿元,同比下降4.91% 拟10派4.3元 | | 回购 | 极米科技 | 拟斥资5000万元至1亿元回购股份 | | 增减持 | 钩威电子 | 珠海晟澜拟减持不超过3%股份 | | 其他 | 粤电力A | 茂名博贺电厂3、4号2×1000MW机组工程项目投产 | | | ST开元 | 公司股票交易可能被实施退市风险警示 に簡屋に | 【热点】 甘咨询(000779.SZ)：拟将子公司交通监理持有的华顺交通80%股权划转至公司子公司建设 ...

Company Announcements - Litong Electronics clarifies that its liquid cooling product development is still in the early discussion stage, and it does not have specific plans for product development or production [2] - Changfei Fiber announces that the global fiber optic cable market environment is normal, and new products related to data centers account for a small proportion of total demand [2] - Rundu Co., Ltd. has a Class 1 innovative drug, but the approval for its injection product remains uncertain [3] - Aorui De plans to invest approximately 145 million yuan in purchasing computing power equipment [3] Investment & Contracts - Jichuan Pharmaceutical's wholly-owned subsidiary has signed an exclusive commercialization cooperation agreement with Beijing Puqi Pharmaceutical Technology Co., Ltd. [4] Equity Changes - Hongxiang Co. plans to transfer 100% equity of Nantong Hanlan to Fujian Mingao for a total price of 120 million yuan, which will help resolve historical debt issues [5] Share Buybacks - Lexin Technology plans to repurchase shares with a total amount between 50 million and 100 million yuan for employee stock ownership or equity incentive [6] - XGIMI Technology also plans to repurchase shares with a total amount between 50 million and 100 million yuan for employee stock ownership or equity incentive [7] Business Performance - Chip导科技 reports a revenue of 394 million yuan for 2025, with a net profit of 106 million yuan, reflecting a 4.91% decrease year-on-year [8] - Sainz plans to engage in molybdenum processing and sales, aiming to recover rhenium [9] - Shenghe Resources announces the unilateral termination of its strategic cooperation with ETM, and it will take legal measures to protect its rights [10] - Lianyun Technology reports a net profit growth of 20.36% for 2025, driven by increased demand for storage products [10] - Shanghai Yizhong reports a staggering net profit growth of 819.42% for 2025, attributed to the inclusion of its core product in the national medical insurance directory [11] Other News - Beiyinmei's controlling shareholder's restructuring plan has been approved by the creditors' meeting, which may lead to changes in shareholder equity [12] - Changchun High-tech's subsidiary has received acceptance for a clinical trial application for a new drug [13][14] - Dingxin Communications' vice president has been warned and fined for suspected short-term trading of company stock [15]

Buyback Announcements - GoerTek has repurchased 1.14% of its shares, spending 1.108 billion yuan, with a total of 40.5481 million shares repurchased at prices ranging from 20.35 to 34.09 yuan per share [18] - Midea Group has repurchased 0.35% of its shares, spending 1.998 billion yuan, with a total of 26.9437 million shares repurchased at prices ranging from 69.50 to 80.44 yuan per share [17] - SF Holding has repurchased approximately 48.2887 million A-shares, with a total amount of about 1.899 billion yuan [1] Stock Trading Anomalies - Maoye Commercial has experienced a significant stock price increase, with a cumulative deviation of 20% over two trading days, indicating potential market overheating and high speculation risk [2] - Jinhui Liquor reported a cumulative stock price deviation of over 20% over three trading days, confirming normal production and no undisclosed major information [3] - Yangtze Optical Fiber has noted that the global optical fiber and cable market environment is normal, with new products related to data centers representing a small proportion of total demand [4] Profit Distribution Plans - Ningbo Fuda plans to distribute a cash dividend of 0.7 yuan per 10 shares, totaling 101 million yuan, which accounts for 59.85% of the net profit attributable to shareholders for the first three quarters of 2025 [5] Corporate Investments - Southwest Securities has received approval from the China Securities Regulatory Commission to issue bonds totaling up to 14 billion yuan [6] - Guoneng Rixin plans to increase its stake in Sanas Zhihui to 31% through an investment of 17.625 million yuan, enhancing its capabilities in new energy asset operation services [7] Production Updates - Weiyuan Co. has successfully launched a 250,000 tons/year electrolyte solvent project, enhancing its production capacity for various chemical products [8] Financial Performance - Lianyun Technology reported a net profit of 142 million yuan for 2025, a year-on-year increase of 20.36%, driven by growth in storage product demand [12] - Shanghai Yizhong reported a net profit of 64.132 million yuan for 2025, a significant increase of 819.42%, attributed to the inclusion of its core product in the national medical insurance directory [13]

证券日报网讯 2月2日，奥瑞德在互动平台回答投资者提问时表示，为保证信息披露的公平性，公司股 东总数信息在定期报告中予以披露，敬请查阅公司已披露的定期报告。 （文章来源：证券日报） ...

Mergers and Acquisitions - Changling Hydraulic plans to acquire 12% of the company's shares at an offer price of 35.82 yuan per share [1] - Chip导科技 intends to purchase 100% equity of Jishun Technology for 403 million yuan and 17.15% equity of Shunlei Technology [2] Share Buybacks - Lexin Technology plans to repurchase shares worth between 50 million to 100 million yuan for employee stock ownership or equity incentives [3] - XGIMI Technology intends to repurchase shares worth between 50 million to 100 million yuan [3] - Lingyun Optical plans to change the purpose of 348.08 million shares for repurchase and cancel them [3] - Midea Group has spent 1.998 billion yuan to repurchase 0.35% of its shares [4] - GoerTek has spent 1.108 billion yuan to repurchase 1.14% of its shares [4] External Investments and Daily Operations - Weiyuan Co. has launched a 250,000 tons/year electrolyte solvent project [5] - Far East Co. signed contracts worth 3.075 billion yuan in January through its subsidiary [6] - Changchun Gaoxin's subsidiary GS3-007a has received approval for clinical trial application for a drug [7] - Aorui De plans to invest approximately 145 million yuan in purchasing computing power equipment to provide services to clients [7] - Electric Power Water Power intends to raise funds not exceeding 3.604 billion yuan through acquisition loans [7] - Guoneng Rixin plans to increase investment of 17.625 million yuan in controlling Sanas Zhihui to enhance new energy asset operation service capabilities [7] - Science plans to engage in molybdenum processing and sales to secure a stable resource supply for rhenium recycling [7] - Panlong Pharmaceutical has received approval for clinical trials of the drug Fluorobiphenyl Patch [8] - Hongxiang Co. plans to transfer 100% equity of Nantong Hanlan New Energy for 120 million yuan [9] - Daon Co. intends to acquire equity in a Vietnamese company for a total purchase price of approximately 15.737 million USD [10] Performance Changes - Shanghai Yizhong expects a net profit of 64.132 million yuan in 2025, a year-on-year increase of 819.42%, with its core product, injectable paclitaxel polymer micelles, included in the national medical insurance directory [11] - Lianyun Technology anticipates a 20.36% year-on-year increase in net profit in 2025, driven by growth in data storage main control chips [12]

奥瑞德公告称，其控股子公司深圳智 算力拟投资1.45亿元实施算力设备采购项目，资金用于采购 服务 器、组网设备及配件等。公司持股深圳智算力99.925%。该项目预计2月开工，建设期3个月，目前处于 筹备阶段。此次投资已获董事会批准，无需股东会审议，不涉及关联交易及重大资产重组。不过，项目 面临实施延期、业绩不确定及行业竞争等风险。 ...

格隆汇2月2日丨奥瑞德(600666.SH)公布，根据公司日常经营需要，公司控股子公司深圳市智算力数字 科技有限公司（称"深圳智算力"）拟投资购买算力设备向客户提供服务，项目投资约1.45亿元，资金主 要用于采购服务器、组网设备及配件等。 ...

关于对外投资项目的公告 证券代码：600666 证券简称：奥瑞德 公告编号：临 2026-006 奥瑞德光电股份有限公司 本次投资额度在董事会权限范围之内，无需提交股东会审议。本次交 易不涉及关联交易，不构成重大资产重组。 相关风险提示： 1、项目实施延期风险：奥瑞德光电股份有限公司（以下简称"公司"）前期 虽已完成项目核心设备供应链调研，但截至本公告披露日尚未签订正式采购合同， 核心设备存在到货延期风险，可能导致项目实施进度不及预期。 2、业绩不确定风险：公司购买算力设备系从事日常经营活动所需。该业务 需进行重资产投入，投资金额较大，后续经营过程中服务费价格可能受宏观经济 及行业政策变化、技术迭代、市场竞争等多重不确定因素影响而发生波动，业绩 存在重大不确定性。 3、行业风险：近年行业竞争日趋激烈，可能引致产能过剩等行业问题，进 而对公司经营业绩产生不利影响。 一、对外投资概述 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 投资标的名称：算力设备采购项目（以下简称"本项目"或"项目"） 投资金额：本项目投资 ...